Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Bone Miner Res. 2017 Mar 27;32(6):1182–1193. doi: 10.1002/jbmr.3094

Table 2b.

Phosphate levels and lumbar spine BMD in RS-I, RS-II, RS-III and MrOS

Model I Model II
n β (95% CI)1 p n β (95% CI)1 p
RS-I
Men 1458 −0.13 (−0.24 to −0.02) 0.021 1437 −0.10 (−0.21 to 0.01) 0.084
Women 2003 −0.21 (−0.31 to −0.11) <0.001 1943 −0.09 (−0.19 to 0.01) 0.084
RS-II
Men 910 −0.19 (−0.34 to −0.04) 0.012 906 −0.18 (−0.32 to −0.03) 0.017
Women 1059 −0.15 (−0.28 to −0.02) 0.027 1051 −0.02 (−0.15 to 0.11) 0.730
RS-III
Men 766 −0.12 (−0.27 to 0.03) 0.126 766 −0.09 (−0.24 to 0.06) 0.238
Women 1039 −0.06 (−0.18 to 0.07) 0.374 1038 0.02 (−0.10 to 0.14) 0.772
RS combined2
Men 3134 −0.14 (−0.22 to −0.07) <0.001 3109 −0.12 (−0.19 to −0.04) 0.002
Women 4101 −0.15 (−0.22 to −0.08) <0.001 4032 −0.04 (−0.10 to 0.03) 0.247
MrOS
Men 5390 −0.02 (−0.08 to 0.04) 0.495 5387 −0.03 (−0.09 to 0.03) 0.360
Studies combined2
Men 8524 −0.07 (−0.11 to −0.02) 0.005 8496 −0.06 (−0.11 to −0.02) 0.007
Women 4101 −0.15 (−0.22 to −0.08) <0.001 4032 −0.04 (−0.10 to 0.03) 0.247
Sex-combined 12625 −0.10 (−0.13 to −0.06) <0.001 12528 −0.06 (−0.09 to −0.02) 0.004

Model I: age adjusted

Model II: age, BMI and smoking adjusted; additional race and site adjustments in MrOS

1

Betas are expressed per 1 mg/dL increase in P levels; BMD is expressed in SD

2

Studies were pooled applying a fixed effects model